{"schema_version":"1","generated_at":"2026-10-30T19:56:35.654Z","data_as_of":null,"url":"https://www.findmykol.com/kol/dhatri-kodali","json_url":"https://www.findmykol.com/kol/dhatri-kodali/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"dhatri-kodali","name":"Dhatri Kodali","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Webster","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1477745800","openalex":"A5077685543"},"summary":"Dhatri Kodali is an Oncology physician. OpenAlex indexes 28 publications with 200 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":28,"cited_by_count":200,"h_index":8,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03053193","title":"MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles","status":"RECRUITING","role":"Site investigator","sponsor":"Agendia","source_url":"https://clinicaltrials.gov/study/NCT03053193","trial_url":"https://www.findmykol.com/trial/NCT03053193"}],"source":"trials"},"payments":{"company_count":47,"program_years":{"first":2021,"last":null},"rows_total":72,"shown":3,"withheld":69,"rows":[{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":105.43,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477745800"},{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":63.21,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477745800"},{"payer":"Eisai Inc.","program_year":2025,"amount_usd":38.64,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1477745800"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1477745800","source":"payments"},"prescribing":{"data_year":2024,"areas_total":9,"areas_shown":3,"areas":[{"area":"Blood & clotting","share_pct":49.5,"classes_total":4,"classes":[{"class":"Erythropoiesis-stimulating Agent","setting":"administered","share_pct":34.5,"drugs":[{"name":"Darbepoetin alfa","share_pct":100}],"max_beneficiaries":25},{"class":"Parenteral Iron Replacement","setting":"administered","share_pct":14.6,"drugs":[{"name":"Iron sucrose","share_pct":100}],"max_beneficiaries":12}]},{"area":"Cancer & immunology","share_pct":22.2,"classes_total":8,"classes":[{"class":"PD-1 inhibitor","setting":"administered","share_pct":20.8,"drugs":[{"name":"Pembrolizumab","share_pct":100}],"max_beneficiaries":15},{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":0.8,"drugs":[{"name":"Anastrozole","share_pct":54.2},{"name":"Letrozole","share_pct":40.7},{"name":"Exemestane","share_pct":5.1}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":19.4,"classes_total":7,"classes":[{"class":"Other antiemetics","setting":"administered","share_pct":17.9,"drugs":[{"name":"Fosaprepitant","share_pct":100}],"max_beneficiaries":20},{"class":"Serotonin-3 Receptor Antagonist","setting":"mixed","share_pct":1.3,"drugs":[{"name":"Palonosetron hcl","share_pct":95.9},{"name":"Ondansetron Hcl","share_pct":4.1}],"max_beneficiaries":20}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":99.7,"facility_pct":0.3},"source":"medicare"},"publications":{"total":21,"shown":5,"withheld":16,"matched_by":"OpenAlex author record","recent":[{"title":"Delayed-onset vitiligo in metastatic HR+/HER2– breast cancer during long-term ribociclib therapy.","year":2025,"journal":"European Journal of Case Reports in Internal Medicine","source_url":"https://doi.org/10.12890/2025_006043","status":"verified"},{"title":"Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis","year":2023,"journal":"Breast Cancer","source_url":"https://doi.org/10.1007/s12282-023-01441-w","status":"verified"},{"title":"Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening","year":2022,"journal":"JAMA Network Open","source_url":"https://doi.org/10.1001/jamanetworkopen.2022.42354","status":"verified"},{"title":"Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010–2017","year":2022,"journal":"Breast Cancer Research and Treatment","source_url":"https://doi.org/10.1007/s10549-022-06604-5","status":"verified"},{"title":"Germline testing in community oncology patients with somatic BRCA1/2 mutations.","year":2021,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.1523","status":"verified"}],"source":"works"},"contact":{"address_1":"501 MEDICAL CENTER BLVD","city":"Webster","state":"TX","zip":"775984219","phone":"281-332-7505","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1477745800","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":69,"publications":16}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2018-05-08","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}